APA (7th ed.) Citation

Gori, S., Inno, A., Rossi, V., Turazza, M., Fiorio, E., Fabi, A., . . . Montemurro, F. Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Gori, Stefania, et al. Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Gori, Stefania, et al. Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study. Public Library of Science (PLoS).